An early look at the second dose completion of the recombinant zoster vaccine in Canadian adults: A retrospective database study

Abstract

Second dose completion of RZV in Canada is high but suboptimal. Further research to understand the factors influencing second dose timing and completion will be an important next step to improve series completion.